Free Trial

FORM Wealth Advisors LLC Makes New $359,000 Investment in Colgate-Palmolive Company (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background

FORM Wealth Advisors LLC acquired a new position in Colgate-Palmolive Company (NYSE:CL - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 3,836 shares of the company's stock, valued at approximately $359,000.

Other hedge funds have also modified their holdings of the company. Legacy Advisors LLC raised its position in Colgate-Palmolive by 24.3% during the first quarter. Legacy Advisors LLC now owns 3,371 shares of the company's stock valued at $316,000 after purchasing an additional 659 shares during the period. Asset Management One Co. Ltd. increased its position in shares of Colgate-Palmolive by 5.3% during the 1st quarter. Asset Management One Co. Ltd. now owns 413,948 shares of the company's stock valued at $38,787,000 after purchasing an additional 21,010 shares during the last quarter. Oppenheimer & Co. Inc. raised its holdings in Colgate-Palmolive by 33.0% during the 1st quarter. Oppenheimer & Co. Inc. now owns 50,915 shares of the company's stock valued at $4,771,000 after buying an additional 12,646 shares during the period. Oppenheimer Asset Management Inc. lifted its position in Colgate-Palmolive by 69.9% in the first quarter. Oppenheimer Asset Management Inc. now owns 23,854 shares of the company's stock worth $2,235,000 after buying an additional 9,815 shares during the last quarter. Finally, Continuum Advisory LLC boosted its stake in Colgate-Palmolive by 31.1% during the first quarter. Continuum Advisory LLC now owns 1,171 shares of the company's stock worth $110,000 after buying an additional 278 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on CL. Wells Fargo & Company raised their target price on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a report on Wednesday, April 2nd. Citigroup increased their price objective on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. UBS Group boosted their target price on Colgate-Palmolive from $105.00 to $109.00 and gave the company a "buy" rating in a research report on Thursday, April 17th. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. Finally, JPMorgan Chase & Co. boosted their price objective on Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a report on Monday, April 28th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $101.69.

View Our Latest Analysis on CL

Colgate-Palmolive Stock Up 1.2%

Shares of CL stock traded up $1.01 during trading hours on Friday, reaching $88.80. 6,946,159 shares of the company's stock were exchanged, compared to its average volume of 4,801,067. The stock's fifty day moving average price is $90.99 and its two-hundred day moving average price is $90.64. The stock has a market cap of $71.97 billion, a PE ratio of 25.09, a PEG ratio of 4.66 and a beta of 0.38. The company has a current ratio of 0.85, a quick ratio of 0.54 and a debt-to-equity ratio of 8.96. Colgate-Palmolive Company has a 1 year low of $85.32 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.05. The firm had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.92 billion. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. The firm's revenue was down 3.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.86 EPS. Research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.34%. Colgate-Palmolive's payout ratio is currently 58.76%.

Colgate-Palmolive announced that its board has approved a stock repurchase plan on Thursday, March 20th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the company to repurchase up to 6.8% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's board believes its shares are undervalued.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines